Hospital as a site of death of cancer patients in Italy: A registry-based analysis and time trends

被引:0
|
作者
Numico, Gianmauro [1 ]
Ippoliti, Roberto [2 ]
Antonuzzo, Andrea [3 ]
Palmero, Lorenza [1 ]
Bossi, Paolo [4 ,5 ]
机构
[1] Azienda Osped S Croce & Carle, Med Oncol, Via M Coppino 26, I-12100 Cuneo, Italy
[2] Univ East Piedmont, Dept Law & Polit Econ & Social Sci DiGSPES, Alessandria, Italy
[3] Fdn IRCCS Ist Nazl Tumori Milano, SSD Cure Supporto Internist & Geriatr, Milan, Italy
[4] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[5] IRCCS Humanitas Res Hosp, Milan, Italy
关键词
Cancer; End of life; Hospital; Site of death; PALLIATIVE CARE; PLACE; COUNTRIES; PEOPLE; END;
D O I
10.1016/j.canep.2024.102702
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Place of death is relevant both for individuals and for the society. Home is universally considered the optimal place of death while dying in hospital may be a signal of inappropriate end-of-life care. We aimed at studying the place of death of patients with cancer in Italy in a five-year period. Patients and methods: The death-certificate database published by the Italian National Institute of Statistics (ISTAT) was analysed, searching the place of death and the main disease related to death. Data from 2015 to 2019 were used, to exclude the influence of the COVID pandemic. Cancer, "cognitive impairment and Alzheimer's disease" (CIAD) and "cardiovascular and cerebrovascular diseases" (CCD) were the examined diseases. The place of death was categorized as "acute care hospital", "hospice" or "other long-term care (LTC) structures" and "home". We implemented an ordinary linear regression model to verify whether there was a statistically significant variation across the selected time (i), and whether a substitution effect among sites of death could be hypothesized (ii). Results: Data on 769,517 deaths were retrieved. In 2019 35.39 % patients with cancer died in hospital, 39.57 % died at home and 20.06 % died in hospice or in other LTC structures. In the examined period, death at home decreased by 3.09 % (95 % C.I. -3.18 - -2.99; p<0.01); death in hospice and long-term structures increased by 2.71 % (95 % C.I. 2.66 - 2.76; p<0.01); death in hospital increased by 0.3 % (95 % C.I. 0.23 - 0.36; p<0.01). For patients with CIAD, death in hospital increased by 0.98 % (95 % C.I. 0.80 - 1.17; p<001) and for patients with CCD decreased by 1.43 % (95 % I.C. - 1.47 - -1.39; p<0.01). Death at home decreased in both diseases. Conclusions: More than one-third of cancer patients die in acute care hospitals and this percentage is slightly increasing in the analysed period. Mortality at home decreased in all the examined diseases. Dying at home is being progressively less frequent, while hospitals continue to represent a frequent place of death.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Predictors of ICU Admission in Patients With Cancer and the Related Characteristics and Outcomes: A 5-Year Registry-Based Study
    Hawari, Feras I.
    Nazer, Lama H.
    Addassi, Awad
    Rimawi, Dalia
    Jamal, Khaled
    CRITICAL CARE MEDICINE, 2016, 44 (03) : 548 - 553
  • [32] The economic burden of prostate cancer A systematic literature overview of registry-based studies
    Fanni, Rencz
    Valentin, Brodszky
    Peter, Varga
    Jozsef, Gajdacsi
    Peter, Nyirady
    Laszlo, Gulacsi
    ORVOSI HETILAP, 2014, 155 (13) : 509 - 520
  • [33] Equitable access to cancer patient pathways in Norway - a national registry-based study
    Olsen, Frank
    Jacobsen, Bjarne K.
    Heuch, Ivar
    Tveit, Kjell M.
    Balteskard, Lise
    BMC HEALTH SERVICES RESEARCH, 2021, 21 (01)
  • [34] The requirements of hospital-based spiritual care for cancer patients
    Moghimian, Maryam
    Irajpour, Alireza
    SUPPORTIVE CARE IN CANCER, 2019, 27 (07) : 2643 - 2648
  • [35] Cost of hepatocellular carcinoma to the national health service in England: a registry-based analysis
    Cullen, Katherine
    Jones, Mari
    Pockett, Rhys D.
    Burton, Anya
    Cross, Timothy J. S.
    Rowe, Ian A.
    Paley, Lizz
    Tataru, Daniela
    Alexander, Graeme
    Marshall, Aileen
    Fitzsimmons, Deborah
    BMJ OPEN GASTROENTEROLOGY, 2023, 10 (01):
  • [36] Time trends in serum cholesterol before cancer death
    Sharp, SJ
    Pocock, SJ
    EPIDEMIOLOGY, 1997, 8 (02) : 132 - 136
  • [37] Cancer incidence during the COVID-19 pandemic by region of residence in Manitoba, Canada: A cancer registry-based interrupted time series study
    Decker, Kathleen M.
    Feely, Allison
    Bucher, Oliver
    Czaykowski, Piotr
    Hebbard, Pamela
    Kim, Julian O.
    Singh, Harminder
    Thiessen, Maclean
    Pitz, Marshall
    Musto, Grace
    Galloway, Katie
    Lambert, Pascal
    CANCER MEDICINE, 2023, 12 (23): : 21465 - 21479
  • [38] Long-term occupational situation after cancer: A French registry-based study
    Saim, Akila
    Gernier, Francois
    Licaj, Idlir
    Rod, Julien
    Velten, Michel
    Klein, Delphine
    Mercier, Mariette
    Joly, Florence
    BULLETIN DU CANCER, 2020, 107 (09) : 867 - 880
  • [39] Use of non-cancer drugs and survival among patients with pancreatic adenocarcinoma: a nationwide registry-based study in Norway
    Stoer, Nathalie C.
    Bouche, Gauthier
    Pantziarka, Pan
    Sloan, Erica K.
    Andreassen, Bettina K.
    Botteri, Edoardo
    ACTA ONCOLOGICA, 2021, 60 (09) : 1146 - 1153
  • [40] Risk of depression after diagnostic prostate cancer workup - A nationwide, registry-based study
    Friberg, Anne Sofie
    Brasso, Klaus
    Larsen, Signe Benzon
    Andersen, Elisabeth Wreford
    Kroyer, Anja
    Helgstrand, John Thomas
    Roder, Martin Andreas
    Klemann, Nina
    Kessing, Lars Vedel
    Johansen, Christoffer
    Dalton, Susanne Oksbjerg
    PSYCHO-ONCOLOGY, 2021, 30 (11) : 1939 - 1947